ATE546437T1 - Aminomethyl-4-imidazole - Google Patents

Aminomethyl-4-imidazole

Info

Publication number: ATE546437T1
Authority: AT; Austria
Prior art keywords: aminomethyl; imidazole
Prior art date: 2006-10-19

Application number

AT07821039T

Other languages

English (en)

Inventor

Guido Galley

Annick Goergler

Zbinden Katrin Groebke

Roger Norcross

Henri Stalder

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-10-19

Filing date

2007-10-09

Publication date

2012-03-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38876376&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE546437(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2007-10-09 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

2012-03-15 Application granted granted Critical

2012-03-15 Publication of ATE546437T1 publication Critical patent/ATE546437T1/de

Links

RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Substances C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

AT07821039T 2006-10-19 2007-10-09 Aminomethyl-4-imidazole ATE546437T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP06122586		2006-10-19
PCT/EP2007/060666 WO2008046757A1 (en)	2006-10-19	2007-10-09	Aminomethyl-4-imidazoles

Publications (1)

Publication Number	Publication Date
ATE546437T1 true ATE546437T1 (de)	2012-03-15

Family

ID=38876376

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT07821039T ATE546437T1 (de)	2006-10-19	2007-10-09	Aminomethyl-4-imidazole

Country Status (20)

Country	Link
US (1)	US8586617B2 (de)
EP (1)	EP2076497B1 (de)
JP (2)	JP5335681B2 (de)
KR (1)	KR101176699B1 (de)
CN (1)	CN101528710B (de)
AR (1)	AR063327A1 (de)
AT (1)	ATE546437T1 (de)
AU (1)	AU2007312390B2 (de)
BR (1)	BRPI0717939A2 (de)
CA (1)	CA2666762C (de)
CL (1)	CL2007002971A1 (de)
ES (1)	ES2381589T3 (de)
IL (1)	IL197877A (de)
MX (1)	MX2009003801A (de)
NO (1)	NO20091478L (de)
PE (1)	PE20080889A1 (de)
RU (1)	RU2009112496A (de)
TW (1)	TW200833685A (de)
WO (1)	WO2008046757A1 (de)
ZA (1)	ZA200902278B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR101176699B1 (ko)	2006-10-19	2012-08-23	에프. 호프만-라 로슈 아게	아미노메틸-4-이미다졸
CA2666489C (en) *	2006-10-19	2012-10-02	F. Hoffmann-La Roche Ag	Imidazolone and imidazolidinone derivatives as 11b-hsd1 inhibitors for diabetes
DK2562162T3 (en) *	2008-01-22	2015-11-23	Dow Agrosciences Llc	N-cyano-4-amino-5-fluoro-pyrimidine derivatives as fungicides
US8242153B2 (en) *	2008-07-24	2012-08-14	Hoffmann-La Roche Inc.	4,5-dihydro-oxazol-2YL derivatives
PL2317851T3 (pl) *	2008-08-01	2014-06-30	Dow Agrosciences Llc	Zastosowanie 5-fluorocytozyny jako fungicydu
JP5539518B2 (ja)	2009-08-14	2014-07-02	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	２−アミノ−５−トリフルオロメチルピリミジン誘導体の位置選択的調製
US8933227B2 (en) *	2009-08-14	2015-01-13	Boehringer Ingelheim International Gmbh	Selective synthesis of functionalized pyrimidines
US8354441B2 (en) *	2009-11-11	2013-01-15	Hoffmann-La Roche Inc.	Oxazoline derivatives
US9452980B2 (en)	2009-12-22	2016-09-27	Hoffmann-La Roche Inc.	Substituted benzamides
AU2011258217B2 (en) *	2010-05-26	2016-12-15	Sunovion Pharmaceuticals Inc.	Heteroaryl compounds and methods of use thereof
KR101651208B1 (ko)	2014-02-19	2016-08-26	충북대학교 산학협력단	클로로겐산 유도체 화합물 및 이를 유효성분으로 포함하는 항염증 및 피부미백용 조성물
WO2017001936A2 (en) *	2015-07-01	2017-01-05	Lifesci Pharmaceuticals, Inc.	Therapeutic inhibitory compounds
WO2017132912A1 (zh) *	2016-02-03	2017-08-10	华东理工大学	苯并脂肪环取代烷基胺类化合物及其用途
MA53755A (fr)	2016-03-17	2021-08-04	Hoffmann La Roche	Dérivé de 5-éthyl-4-méthyl-pyrazole-3-carboxamide ayant une activité comme agonist de taar
WO2017190050A1 (en) *	2016-04-28	2017-11-02	Cornell University	Inhibitors of soluble adenylyl cyclase
EP3463359A4 (de) *	2016-06-02	2020-08-26	Purdue Pharma LP	Spurenamin-assoziierte rezeptor-1-agonisten und partielle agonisten zur schmerzbehandlung
WO2023033679A1 (en)	2021-09-01	2023-03-09	Limited Liability Company «Excellena Research And Development» (Llc «Excellena»)	(azacycloalkyl)methoxy-substituted benzamides as modulators of trace amine-associated receptor 1 (taar1)
WO2023033680A1 (en)	2021-09-01	2023-03-09	Limited Liability Company «Excellena Research And Development» (Llc «Excellena»)	Substituted 2,3,4,5-tetrahydrobenzo[ f][1,4]oxazepines as modulators of trace amine-associated receptor 1 (taar1)
WO2023033681A1 (en)	2021-09-01	2023-03-09	Limited Liability Company «Excellena Research And Development» (Llc «Excellena»)	Substituted 2-(5-aryl-4 h-1,2,4-triazol-3-yl)ethanamines as modulators of trace amine-associated receptor 1 (taar1)

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2731471A (en)		1956-01-17		Nxg hi
FR6551E (fr)	1905-07-27	1906-12-17	Carlo Chiesa	Séchoir à tambour rotatif, démontable et transportable, et fonctionnant à ciel ouvert, pour cocons, céréales, etc.
US2161938A (en)	1934-07-31	1939-06-13	Soc Of Chemical Ind	Imidazolines
US2457047A (en)	1946-02-13	1948-12-21	Monsanto Chemicals	2-(2'-thenyl)-4, 5-dihydroimidazoles and process for making the same
US2778836A (en)	1954-04-02	1957-01-22	Union Chimique Belge Sa	Substituted 2-methyl-delta2 imidazolines
US2744910A (en)	1955-06-27	1956-05-08	Bristol Lab Inc	2-(ortho-benzylbenzyl)-imidazoline and acid addition salts
US2744909A (en)	1955-06-27	1956-05-08	Bristol Lab Inc	2-(ortho-phenylbenzyl) imidazoline and acid addition salts
US2919274A (en)	1957-09-17	1959-12-29	Sahyun Melville	Amidines
GB877306A (en)	1958-04-21	1961-09-13	Pfizer & Co C	Halogenated derivatives of tetrahydro-1-naphthyl cyclic amidines
DE1121054B (de)	1960-11-23	1962-01-04	Merck Ag E	Verfahren zur Herstellung eines neuen Imidazolinderivates und dessen Saeureadditionssalzen
US3202660A (en)	1961-10-09	1965-08-24	Boehringer Sohn Ingelheim	Process for the preparation of 3-arylamino-1, 3-diazacycloalkenes
DE1150180B (de)	1962-04-12	1963-06-12	Merck Ag E	Mittel zur Vorbehandlung der Haut fuer die Rasur
ES323985A1 (es)	1966-02-26	1966-12-16	Blade Pique Juan	Procedimiento para la obtenciën de derivados del imidazol
US3377247A (en)	1967-04-28	1968-04-09	Dow Chemical Co	Antidepressant method
US3586695A (en)	1968-01-26	1971-06-22	Dow Chemical Co	Substituted imidazolinyl indoles
BE754935A (fr)	1969-08-13	1971-02-17	Hoechst Ag	2-(thienyl-3'-amino)-1,3-diazacycloalcenes et leur preparation
US3818094A (en)	1969-08-28	1974-06-18	Boehringer Sohn Ingelheim	Hypotensive pharmaceutical compositions containing certain 2-anilino-1,3-diazacyclopentenes-(2)
US3622579A (en)	1969-08-28	1971-11-23	Boehringer Sohn Ingelheim	Derivatives of 2-anilino-1,3-diazacyclopentene-(2)
US3660423A (en)	1970-02-13	1972-05-02	Dow Chemical Co	2-(substituted benzyl)methyl-2-imidazolines
GB1333471A (en)	1971-01-27	1973-10-10	Labaz	Imidazoline derivatives and process for preparing the same
US4125620A (en)	1974-10-01	1978-11-14	Boehringer Ingelheim Gmbh	2-[(2',6'-Disubstituted-phenyl)-imino]-imidazolidines and salts thereof
US3992403A (en)	1975-05-30	1976-11-16	Schering Corporation	2-Imidazolines and their use as hypoglycemic agents
GB1538097A (en)	1976-01-26	1979-01-10	Lafon Labor	Substituted phenyl-amidines
US4323570A (en)	1978-11-15	1982-04-06	Beiersdorf Aktiengesellschaft	Substituted aminopyrimidines
AU518569B2 (en)	1979-08-07	1981-10-08	Farmos-Yhtyma Oy	4-benzyl- and 4-benzoyl imidazole derivatives
GB2110663B (en) *	1981-12-04	1985-08-07	Farmos Group Ltd	Imidazole derivatives
US4505918A (en) *	1982-11-08	1985-03-19	Merck & Co., Inc.	4-[2-Pyridinylthio(oxy or amino)methyl]-1H-imidazoles and derivatives
US4540705A (en)	1983-03-14	1985-09-10	Sterling Drug Inc.	Antidepressant imidazolines and related compounds
EP0166937B1 (de)	1984-06-06	1991-08-28	Abbott Laboratories	Adrenergische Verbindungen
US4665095A (en)	1985-12-11	1987-05-12	Abbott Laboratories	Use of 2-[(3,5-dihalo-4-aminobenzyl)]imidazolines to stimulate alpha-1 adrenergic receptors and to treat nasal congestion
JPH0774205B2 (ja) *	1986-12-04	1995-08-09	三井石油化学工業株式会社	新規イミダゾ−ル誘導体
GB2215206B (en)	1988-02-29	1991-07-03	Farmos Oy	4-substituted imidazole derivatives useful in perioperative care
FI894911A0 (fi)	1989-10-17	1989-10-17	Farmos Oy	En terapeutiskt vaerdefull foerening.
FR2692893B1 (fr) *	1992-06-24	1994-09-02	Sanofi Elf	Dérivés alkylamino ramifiés du thiazole, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
DE69534283T2 (de)	1993-10-13	2006-03-16	Horacek, H. Joseph	Clonidinhaltiges arzneimittel mit verzögerter wirkstoffabgabe
GB9425211D0 (en)	1994-12-14	1995-02-15	Ucb Sa	Substituted 1H-imidazoles
US5610174A (en)	1995-06-02	1997-03-11	Synaptic Pharmaceutical Corporation	Use of α1A -selective adrenoceptor agonists for the treatment of urinary incontinence
GB9520150D0 (en)	1995-10-03	1995-12-06	Orion Yhtymae Oy	New imidazole derivatives
DE19607487C2 (de)	1996-02-28	1998-09-10	Byk Gulden Lomberg Chem Fab	Verwendung von alpha1-Adrenoceptor-Antagonisten
US5969137A (en)	1996-09-19	1999-10-19	Virginia Commonwealth University	Benzylamidine derivatives with serotonin receptor binding activity
IL123232A0 (en)	1997-02-11	1999-11-30	Lilly Co Eli	Medicament for inhibiting glucose metabolism deterioration
US5866579A (en)	1997-04-11	1999-02-02	Synaptic Pharmaceutical Corporation	Imidazole and imidazoline derivatives and uses thereof
HUP0004557A3 (en)	1997-12-04	2002-03-28	Allergan Inc Irvine	Substituted imidazole derivatives having agonist-like activity at alpha 2b or 2b/2c adrenergic receptors and pharmaceuticals containing the same
US6841684B2 (en)	1997-12-04	2005-01-11	Allergan, Inc.	Imidiazoles having reduced side effects
ES2198033T3 (es)	1997-12-19	2004-01-16	Eli Lilly And Company	Compuestos de imidazolina hipoglucemicos.
ATE293102T1 (de)	1998-04-23	2005-04-15	Takeda Pharmaceutical	Naphthalene derivate ,ihre herstellung und verwendung
ES2150378B1 (es)	1998-08-07	2001-07-01	Esteve Labor Dr	Empleo de derivados de aril(o heteroaril)azolilcarbinoles en la elaboracion de un medicamento para el tratamiento de los trastornos mediados por un exceso de substancia p.
CA2246027A1 (en)	1998-08-27	2000-02-27	Virginia Commonwealth University	Benzylamidine derivatives with serotonin receptor binding activity
PE20010781A1 (es)	1999-10-22	2001-08-08	Takeda Chemical Industries Ltd	Compuestos 1-(1h-imidazol-4-il)-1-(naftil-2-sustituido)etanol, su produccion y utilizacion
FI20000073A0 (fi)	2000-01-14	2000-01-14	Orion Yhtymae Oy	Uusia imidatsolijohdannaisia
JP2001302643A (ja)	2000-04-21	2001-10-31	Suntory Ltd	環状アミジン化合物
EP1319070A2 (de)	2000-09-12	2003-06-18	Oregon Health & Science University	Säuger-rezeptorgene und verwendungen davon
IL155436A0 (en)	2000-11-14	2003-11-23	Hoffmann La Roche	Substituted 2-phenylaminoimidazoline phenyl ketone derivatives as ip antagonists
IL147921A0 (en)	2002-01-31	2002-08-14	Abdulrazik Mohammad	A method for treating central nervous system disorders by ocular dosing
TW200930291A (en)	2002-04-29	2009-07-16	Bayer Cropscience Ag	Pesticidal heterocycles
KR100492252B1 (ko)	2002-08-09	2005-05-30	한국화학연구원	이미다졸을 포함하는 이차아민으로 치환된 벤조피란유도체 및 그의 제조방법
WO2004018419A2 (en) *	2002-08-23	2004-03-04	Chiron Corporation	Benzimidazole quinolinones and uses thereof
MXPA05002571A (es) *	2002-09-04	2005-09-08	Schering Corp	Pirazolopirimidinas como inhibidores de cinasa dependientes de ciclina.
AU2003278249B8 (en)	2002-09-05	2010-11-18	Aventis Pharma S.A.	Novel aminoindazole derivatives as medicines and pharmaceutical compositions containing same
AU2006242109A1 (en) *	2005-05-03	2006-11-09	Bayer Cropscience Ag	Insecticidal substituted aminoalkyl heterocyclic and heteroaryl derivatives
US20090170907A1 (en) *	2005-06-06	2009-07-02	Smithkline Beecham Corporation	Chemical Compounds
US7803828B2 (en)	2005-08-25	2010-09-28	Schering-Plough Corporation	Functionally selective alpha2C adrenoreceptor agonists
EP2311814A1 (de)	2005-12-01	2011-04-20	F. Hoffmann-La Roche AG	2,4,5-Triphenylimidazolinderivate als Inhibitoren der Wechselwirkung zwischen P53 und MDM2-Proteinen zur Verwendung als Antikrebsmittel
NL2000439C2 (nl)	2006-01-20	2009-03-16	Quark Biotech	Therapeutische toepassingen van inhibitoren van RTP801.
RU2008130448A (ru) *	2006-01-27	2010-03-10	Ф. Хоффманн-Ля Рош Аг (Ch)	Применение производных 4-имидазола для расстройств цнс
CL2007002994A1 (es)	2006-10-19	2008-02-08	Wyeth Corp	Compuestos derivados heterociclicos que contienen sulfamoilo, inhibidores de hsp90; composicion farmaceutica; y uso para el tratamiento del cancer, tal como cancer de mama, de colon y prostata, entre otros.
ATE462696T1 (de)	2006-10-19	2010-04-15	Hoffmann La Roche	Aminomethyl-2-imidazole mit affinität zu mit dem trace-amin assoziierten rezeptoren
CA2666489C (en)	2006-10-19	2012-10-02	F. Hoffmann-La Roche Ag	Imidazolone and imidazolidinone derivatives as 11b-hsd1 inhibitors for diabetes
KR101176699B1 (ko) *	2006-10-19	2012-08-23	에프. 호프만-라 로슈 아게	아미노메틸-4-이미다졸

2007
- 2007-10-09 KR KR1020097007948A patent/KR101176699B1/ko not_active IP Right Cessation
- 2007-10-09 CN CN2007800388091A patent/CN101528710B/zh not_active Expired - Fee Related
- 2007-10-09 AU AU2007312390A patent/AU2007312390B2/en not_active Ceased
- 2007-10-09 MX MX2009003801A patent/MX2009003801A/es active IP Right Grant
- 2007-10-09 JP JP2009532767A patent/JP5335681B2/ja not_active Expired - Fee Related
- 2007-10-09 ES ES07821039T patent/ES2381589T3/es active Active
- 2007-10-09 CA CA2666762A patent/CA2666762C/en not_active Expired - Fee Related
- 2007-10-09 AT AT07821039T patent/ATE546437T1/de active
- 2007-10-09 WO PCT/EP2007/060666 patent/WO2008046757A1/en active Application Filing
- 2007-10-09 RU RU2009112496/04A patent/RU2009112496A/ru not_active Application Discontinuation
- 2007-10-09 EP EP07821039A patent/EP2076497B1/de not_active Not-in-force
- 2007-10-09 BR BRPI0717939-1A2A patent/BRPI0717939A2/pt not_active IP Right Cessation
- 2007-10-15 US US11/872,203 patent/US8586617B2/en not_active Expired - Fee Related
- 2007-10-17 TW TW096138932A patent/TW200833685A/zh unknown
- 2007-10-17 PE PE2007001403A patent/PE20080889A1/es not_active Application Discontinuation
- 2007-10-17 CL CL200702971A patent/CL2007002971A1/es unknown
- 2007-10-17 AR ARP070104590A patent/AR063327A1/es unknown
2009
- 2009-03-26 IL IL197877A patent/IL197877A/en not_active IP Right Cessation
- 2009-04-01 ZA ZA200902278A patent/ZA200902278B/xx unknown
- 2009-04-17 NO NO20091478A patent/NO20091478L/no not_active Application Discontinuation
2013
- 2013-05-02 JP JP2013096834A patent/JP5567177B2/ja not_active Expired - Fee Related

Also Published As

Publication number	Publication date
AU2007312390A1 (en)	2008-04-24
AU2007312390B2 (en)	2013-03-28
ZA200902278B (en)	2010-03-31
JP2010506875A (ja)	2010-03-04
JP5335681B2 (ja)	2013-11-06
CA2666762A1 (en)	2008-04-24
CN101528710A (zh)	2009-09-09
MX2009003801A (es)	2009-04-22
US8586617B2 (en)	2013-11-19
BRPI0717939A2 (pt)	2013-12-03
WO2008046757A1 (en)	2008-04-24
CL2007002971A1 (es)	2008-05-30
KR20090055035A (ko)	2009-06-01
EP2076497A1 (de)	2009-07-08
JP5567177B2 (ja)	2014-08-06
PE20080889A1 (es)	2008-06-27
US20080119535A1 (en)	2008-05-22
CN101528710B (zh)	2012-11-07
TW200833685A (en)	2008-08-16
EP2076497B1 (de)	2012-02-22
IL197877A (en)	2015-07-30
ES2381589T3 (es)	2012-05-29
JP2013173779A (ja)	2013-09-05
NO20091478L (no)	2009-05-05
KR101176699B1 (ko)	2012-08-23
CA2666762C (en)	2014-12-30
AR063327A1 (es)	2009-01-21
RU2009112496A (ru)	2010-11-27
IL197877A0 (en)	2009-12-24

Publication	Publication Date	Title
DK2081937T3 (da)	2012-10-01	Triazolopyridazin-proteinkinasemodulatorer
DE602006019782D1 (de)	2011-03-03	Kapselperforationsmodul
DE602007002544D1 (de)	2009-11-05	Nuancierungsmittel
DE602007008423D1 (de)	2010-09-23	Flüssigkeitshärtung
DE602007003893D1 (de)	2010-02-04	Kippambossanordnung
DE602007009267D1 (de)	2010-10-28	Reifenaufblasverfahren
DE602007009650D1 (de)	2010-11-18	Spiroindolinonderivate
DE602007006947D1 (de)	2010-07-15	Pyridopyrimidinonderivate
DE602007000258D1 (de)	2009-01-02	Kassetteneinspannmechanismus
DE602006020192D1 (de)	2011-03-31	Riemenscheibenanorndung
DE602007001280D1 (de)	2009-07-30	Getränkeextraktor
AT504580A3 (de)	2008-07-15	Scan-einrichtung
DE602007008400D1 (de)	2010-09-23	Kaliummonopersulfatlösungen
DE602007010359D1 (de)	2010-12-16	Azaspiroderivate
DE602006019150D1 (de)	2011-02-03	Riemenscheibenanorndung
ATE546437T1 (de)	2012-03-15	Aminomethyl-4-imidazole
DE502007000218D1 (de)	2008-12-18	nsetzungen
DE502007002453D1 (de)	2010-02-11	Kunstoffverdichtergehäuse
DE602007010544D1 (de)	2010-12-30	Motorstatorstruktur
DE602007000501D1 (de)	2009-03-12	Breitbandrichtkoppler
DE602007007460D1 (de)	2010-08-12	Sehkrafttestsystem
DE602006016174D1 (de)	2010-09-23	Blisterverpackungsverfahren
DE602007004080D1 (de)	2010-02-11	Tintenstrahlaufnehmer
DE502007000361D1 (de)	2009-02-26	Stanznieteinheit
DE502007001629D1 (de)	2009-11-12	Rfahren